Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | GFER | P55789 | 1/20 | 0.42 |
| ▸ | DCLK1 | O15075 | 1/20 | 0.42 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.42 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.42 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.42 |
| ▸ | CSF1R | P07333 | 1/20 | 0.42 |
| ▸ | FER | P16591 | 1/20 | 0.42 |
| ▸ | CDK2 | P24941 | 1/20 | 0.42 |
| ▸ | MARK3 | P27448 | 1/20 | 0.42 |
| ▸ | FLT4 | P35916 | 1/20 | 0.42 |
| ▸ | FLT3 | P36888 | 1/20 | 0.42 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.42 |
| ▸ | CSNK1D | P48730 | 1/20 | 0.42 |
| ▸ | CLK2 | P49760 | 1/20 | 0.42 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.42 |
| ▸ | CSNK1G2 | P78368 | 1/20 | 0.42 |
| ▸ | MAP4K2 | Q12851 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29484273 | 0.87 | GP6 (0.42) | ALOX15ALDH1A1MAPTGFERDCLK1 | |
| SCHEMBL17900083 | 0.87 | GP6 (0.42) | ALOX15ALDH1A1MAPTGFERDCLK1 | |
| SCHEMBL2148744 | 0.81 | LMNA (0.40) | MAPTCDK2MAPK9IDO1MAPK10 | |
| SCHEMBL6155891 | 0.79 | PDE3B (0.39) | ALOX15ALDH1A1MAPTKDM4EGAA | |
| SCHEMBL1555150 | 0.79 | ERBB2 (0.41) | ALDH1A1PRKD3MAP4K4MAPK9CSNK1D | |
| SCHEMBL3848746 | 0.79 | ERBB2 (0.41) | MKNK2KDM4EGAAALPLNPSR1 | |
| SCHEMBL2122515 | 0.79 | CYP2A6 (0.48) | ALOX15ALDH1A1MAPTKDM4EHPGD | |
| SCHEMBL4305212 | 0.78 | ROCK2 (0.56) | MAPTCHEK2CSF1RCDK2MARK3 | |
| SCHEMBL26110065 | 0.77 | IDO1 (0.44) | ALDH1A1GFERKDM4EGAAIDO1 | |
| SCHEMBL218119 | 0.77 | ALOX15 (0.52) | ALOX15ALDH1A1MAPTGFERKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 131 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1063440-C | Process for the desulfurization and the desalting of fossil fuels | RHONE ROULENC AGROCHIMIE CORP (FR) | 2001-03-21 | — | — | CN | claimed |
| CN-1079735-A | Arylpyrazole mycocide | ENERGY BIOSYSTEMS CORP (FR) | 1993-12-22 | — | — | CN | claimed |
| US-20250236608-A1 | EGFR INHIBITORS | BLUEPRINT MEDICINES CORPORATION | 2025-07-24 | — | — | US | disclosed |
| EP-4584259-A1 | CK1ALPHA AND DUAL CK1ALPHA / GSPT1 DEGRADING COMPOUNDS | Innovo Therapeutics, Inc. (US) | 2025-07-16 | — | — | EP | disclosed |
| EP-4504719-A1 | EGFR INHIBITORS | Blueprint Medicines Corporation (US) | 2025-02-12 | — | — | EP | disclosed |
| CN-119325471-A | EGFR inhibitors | 缆图药品公司 | 2025-01-17 | — | — | CN | disclosed |
| CN-113166140-B | CDK8/19 inhibitors | 拜奥卡德联合股份公司 | 2024-06-14 | — | — | CN | disclosed |
| US-20240158370-A1 | CK1 alpha AND DUAL CK1 alpha / GSPT1 DEGRADING COMPOUNDS | INNOVO THERAPEUTICS, INC. | 2024-05-16 | — | — | US | disclosed |
| WO-2024054832-A1 | CK1α AND DUAL CK1α / GSPT1 DEGRADING COMPOUNDS | INNOVO THERAPEUTICS, INC. (US) | 2024-03-14 | — | — | WO | disclosed |
| US-11840531-B2 | CDK8/19 inhibitors | JOINT STOCK COMPANY "BIOCAD" (RU) | 2023-12-12 | — | — | US | disclosed |
| WO-2023196283-A1 | EGFR INHIBITORS | BLUEPRINT MEDICINES CORPORATION (US) | 2023-10-12 | — | — | WO | disclosed |
| US-5663119-A | FOR USE IN AGRICULTURE | RHONE-POULENC AGROCHIMIE (FR) | 1997-09-02 | — | — | US | disclosed |
| CN-1131151-A | Method for preparation of 3-phenyl pyrazole derivant | RHONE POULENC AGROCHIMIE (FR) | 1996-09-18 | — | — | CN | disclosed |
| US-5523280-A | TREATING PLANT DISEASES | RHONE-POULENC AGROCHIMIE (FR) | 1996-06-04 | — | — | US | disclosed |
| EP-0638070-A1 | FUNGICIDAL ARYLPYRAZOLES | RHONE-POULENC AGROCHIMIE (FR) | 1995-02-15 | — | — | EP | disclosed |
| CN-1079735-A | Arylpyrazole mycocide | ENERGY BIOSYSTEMS CORP (FR) | 1993-12-22 | — | — | CN | disclosed |
| WO-1993022287-A1 | FUNGICIDAL ARYLPYRAZOLES | RHONE POULENC AGROCHIMIE (FR) | 1993-11-11 | — | — | WO | disclosed |
| EP-0538156-A1 | Fungicidal phenylpyrazoles | RHONE-POULENC AGROCHIMIE (FR) | 1993-04-21 | — | — | EP | disclosed |
| CN-1071162-A | Novel phenylpyrazole fungicides | RHONE POULENC AGROCHIMIE (FR) | 1993-04-21 | — | — | CN | disclosed |
| US-4072498-A | HERBICIDES | THE UPJOHN COMPANY (US) | 1978-02-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11840531-B2 | CDK8/19 inhibitors | CDK8, CDK9, CDK18 | ALOX15 3601/4885ALDH1A1 3487/4885MAPT 1595/4885 |
| US-20240158370-A1 | CK1 alpha AND DUAL CK1 alpha / GSPT1 DEGRADING COMPOUNDS | CKS1B, CKS2, MARK1 | ALOX15 3260/4885ALDH1A1 1687/4885MAPT 768/4885 |
| US-20250236608-A1 | EGFR INHIBITORS | EGFR, ERBB2, ERBB3 | ALOX15 4747/4885ALDH1A1 2147/4885MAPT 2806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.